Navigation Links
pocH-100i Hematology Analyzer

ProductspocH-100i Hematology Analyzer
Company Sysmex America, Inc.
Item pocH-100i Hematology Analyzer
Features 
  • Extremely compact & light design (W185 x H350 x D460)
  • Simple '2 step' operation to obtain test results
  • Easy operation with user friendly illustrated icons & color touch screen
  • Non cyanide HGB analysis meaning a safe testing environment
  • Internal thermal printer prints all analysis data & flags; three different printout formats are available to suit individual requirements
  • Uses Hydrodynamic focusing DC detection method, providing precise, reliable test results (RBC & PLT)
Description The Sysmex pocH-100i is the first Sysmex hematology analyzer designed for a laboratory with low daily testing requirements. With its small footprint, closed tube sampling, and a 3-part differential from just 15 L of whole blood sample, you have a solution for any small healthcare site including the emergency room, surgical suite, or small clinic. The differential on the Sysmex pocH-100i includes a true neutrophil count, a real benefit to physicians evaluating diagnostic needs for a patient. In addition, intuitive operational features of this 17-parameter instrument make it simple to operate.

The Sysmex pocH-100i is built on the proven technology and reliability of the Sysmex K-Series analyzers, which has provided accurate testing for the small volume laboratory for over 20 years. The reliability of this series of analyzers is based on Direct Current (DC) technology for measurement of red cells, white cells and platelets. The pocH-100i also utilizes hydrodynamic focusing for the most accurate red cell and platelet counting. As with all Sysmex instrumentation, a non-cyanide Hemoglobin method is used. The pocH-100i is designed to provide you with ease-of-operation and results you can trust when testing in a CLIA non-waived laboratory.

Info Sysmex America, Inc.Call Sysmex America, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-394-3469

Customer Service: 1-800-379-7639
Web site: http://www.sysmex.com/

Related medicine products :

1. Coulter LH 755 Hematology Workcell
2. Coulter LH 750 Hematology Analyzer
3. COULTER LH 755 Hematology Workcell
4. COULTER LH 750 Hematology Analyzer
5. COULTER MAXM Hematology Analyzer
6. COULTER HmX Hematology Analyzer
7. Sysmex XE-2100™ Automated Hematology Analyzer
8. ADVIA 60 Hematology System
9. ADVIA 70 Hematology System
10. ADVIA 120 Hematology System
11. Aerospray Hematology Slide Stainer/Cytocentrifuge
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products:
(Date:11/21/2008)...wire-FirstCall/ -- Today, prescription drugs are t...ng 88 percent of patients suffering chronic condit...hronic condition account for 96 percent of all pre...cal costs. A proprietary new pharmacy model devel...nc. (NYSE: MHS ) significantly reduces critical ...
(Date:11/21/2008)...seits cause remains a mysteryswept into Athens. Th...s, soldiers and refugees of the war then raging be...rpses, social order broke down. Over the next thre...t a third of its population. It lost the war too. ...nd of the Golden Age of Greece. , The Plague of...
(Date:11/21/2008)...stCall/ -- Symmetry Medical Inc. (NYSE: SMA ), a...lobal orthopedic device industry and other medical...sident and Chief Executive Officer, and Fred L. Hi...cer, are scheduled to present at the 20th Annual P...k Palace Hotel on Wednesday, December 3, 2008 at 1...
(Date:11/21/2008)... 2008) How can moss help us to treat Alzheimer,s... us about evolution? Can genetic studies of snapd...re species? What can quail teach us about human a... studies of choanoflagellates unravel the origins ...s in biology, scientists are increasing the array ...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:A new world of research possibilities with 'Emerging Model Organisms' 2
...med the Stern Review as a timely and authoritative...imate change on the world’s human population if th...ssioned by the UK Government and prepared by forme...holas Stern, the report has been described by Brit...
...n the tourism industry with the scenic beauty of t...l over the world. The latest buzzword in Kerala i...ing to have cracked the winning combination of fun...ar-old Clay Andersson from Carolina have already e...
...are presenting research today on a more effective ...responsive to current// drug therapies. They hav... a highly potent Interferon, is nearly twice as ef...n standard treatments. They are sharing their find...
...of us can recall having difficulty deciphering hea...u have stopped taking a// prescription too soon be...ether poor vision prevents you from accurately rea...alth literacy can get in the way of good health ca...
Other Medicine News:Health News:A Timely Reminder Of Devastating Health Impact Of Climate Change 2Health News:Kerala to Venture into Medical Tourism 2Health News:Making Headway Against Hepatitis C 2Health News:Low Health Literacy Interferes with Good Health Care 2
(Date:11/20/2008)...PRNewswire/ -- Epeius Biotechnologies,announced t...exin-G in,chemotherapy-resistant metastatic soft ...Dr. Sant P. Chawla, principal investigator, at the...ovember 13-15, 2008. Patients received,repeated i...ths. Analysis of,safety and efficacy data showed ...
(Date:11/20/2008)...DELPHIA, Nov. 20 GlaxoSmi...ited States Food and Drug Administration (FDA) gra...opag) for the treatment of thrombocytopenia in pat...penic purpura (ITP) who have had an insufficient r...enectomy. The approval is a significant milestone ...
(Date:11/20/2008)...RNewswire/ -- Milk. It does a body good. And,now ... After years of,research, scientists at OncoNutri...milk that stimulate the body,s own production of a...ews Release, go to:, http://www.prnewswire.com/mnr... new cancer therapies, the chief scientist, Dr. Da...
(Date:11/20/2008)...Newswire/ -- Radius Health ("Radius") announced to...o its second institutional financing round, increa...d the total amount raised since the company,s ince...l investors participated in the financing, led by ...pital, The Wellcome Trust, HealthCare Ventures, Ox...
Breaking Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Heritage Valley Health System Named a Finalist for Microsoft Healthcare User Group Award 10765 1Heritage Valley Health System Named a Finalist for Microsoft Healthcare User Group Award 10765 2Congressional Briefing on Pre Diabetes and Vision Health 10762 1Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions 28DDS 29 10759 1Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions 28DDS 29 10759 2Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions 28DDS 29 10759 3Bobbi Brown Cosmetics Creates Limited Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show 10757 1Bobbi Brown Cosmetics Creates Limited Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show 10757 2
...buting Editor , ,Positive patient identificat...bodies for the past few years. Until recently, th... beyond the reach of the average hospital or labor...ces that can be integrated into a facilitys IS req...small facilities, while others are best for larger...
...tor , ,Quality Control (QC) materials and pro...d patients by verifying accuracy and precision of ...e a valuable resource, designing customized QC mat...hat analytical error stays within acceptable limit...y,s laboratories is a demanding business. Although...
Other Medicine Technology:Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4New Quality Control Systems for Every Laboratory Application 2New Quality Control Systems for Every Laboratory Application 3